| Literature DB >> 34852176 |
Rosalie C Warner1, Ryan C Chapman1, Brianna N Davis1, Paul H Davis1.
Abstract
Toxoplasma gondii is an apicomplexan parasite that affects both humans and livestock. Transmitted to humans through ingestion, it is the second-leading cause of foodborne illness-related death. Currently, there exists no approved vaccine for humans or most livestock against the parasite. DNA vaccines, a type of subunit vaccine which uses segments of the pathogen's DNA to generate immunity, have shown varying degrees of experimental efficacy against infection caused by the parasite. This review compiles DNA vaccine efforts against Toxoplasma gondii, segmenting the analysis by parasite antigen, as well as a review of concomitant adjuvant usage. No single antigenic group was consistently more effective within in vivo trials relative to others. © American Society of Parasitologists 2021.Entities:
Keywords: zzm321990 Toxoplasma gondiizzm321990 ; Adjuvants; Antigens; DNA vaccines
Mesh:
Substances:
Year: 2021 PMID: 34852176 PMCID: PMC8638329 DOI: 10.1645/20-157
Source DB: PubMed Journal: J Parasitol ISSN: 0022-3395 Impact factor: 1.276